tirzepatide cortisol study as Compared with Semaglutide for the Treatment of Obesity The GLP-1/GIP dual-receptor agonist tirzepatide

The net benefit of GLP-1s also depends on patients willingness to accept harms, researchers said

its the reversal of metabolic syndrome and the reduction of cardiovascular risk

Curcumin attenuates TNF-alpha-induced expression of intercellular adhesion molecule-1, vascular cell adhesion molecule-1 and proinflammatory cytokines in human endometriotic stromal cells

Clinical trial data tells a clear story

We look forward to a future where there is a personalized approach to treatments. In June 2024, researchers submitted data to the FDA seeking approval for tirzepatide as a treatment for sleep apnea in people with obesity